IP Library Granted Patent US 11,027,049
Granted Patent B2
US 11,027,049 · App. 15/994,263 · Granted Jun 8, 2021

Devices and methods for delivery of bioactive agents

Inventors: Ralph A. Chappa (Ham Lake, MN); Andrew G. Bach (Edina, MN)
Assignee: Surmodics, Inc.
A61L29/085A61L29/16A61L2300/416A61L2300/60
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,027,049
App. No.
15/994,263
Granted
Jun 8, 2021
Kind
B2
Abstract

Embodiments of the invention include bioactive agent eluting devices. In an embodiment the invention includes a bioactive agent delivery device including a substrate, a hydrophilic polymer disposed on the substrate, and a substantially amorphous bioactive agent disposed on the surface of the hydrophilic polymer. In an embodiment, the invention includes a method of making a bioactive agent delivery device including depositing a hydrophilic polymer on a substrate forming a hydrophilic surface and depositing a substantially amorphous bioactive agent on the hydrophilic surface. In an embodiment, the invention includes a bioactive agent-eluting catheter including a catheter shaft and an expandable balloon disposed on the catheter shaft. Other embodiments are included herein.

Claims (22)

1. A bioactive agent delivery device comprising:

an expandable substrate forming part of a balloon;

a hydrophilic polymer layer disposed over the substrate, the hydrophilic polymer layer comprising a hydrophilic polymer comprising poly(ethylene glycol); and

a hydrophobic bioactive agent composition layer disposed over the surface of the hydrophilic polymer layer, the hydrophobic bioactive composition layer comprising one or more forms of paclitaxel; and

wherein the hydrophobic bioactive agent composition layer lacks the hydrophilic polymer.

2. The bioactive agent delivery device of claim 1 , the bioactive agent composition comprising trace amounts of a solvent that does not solvate the hydrophilic polymer layer.

3. The bioactive agent delivery device of claim 1 , further comprising a catheter shaft, wherein the expandable substrate forming part of the balloon is disposed on the catheter shaft.

4. The bioactive agent delivery device of claim 1 , wherein the hydrophilic polymer layer is covalently bonded to the expandable substrate through the reaction product of a latent photoreactive group.

5. The bioactive agent delivery device of claim 1 , the expandable substrate comprising an elastomeric material.

6. The bioactive agent delivery device of claim 1 , the expandable substrate comprising a polyamide.

7. The bioactive agent delivery device of claim 1 , wherein the thickness of the expandable substrate is from 5 μm to 100 μm.

8. The bioactive agent delivery device of claim 1 , wherein the hydrophilic polymer layer is cross-linked through the reaction product of a latent photoreactive group.

9. The bioactive agent delivery device of claim 1 , wherein the paclitaxel releases from the device into an aqueous environment in under 30 seconds when exposed to an aqueous environment.

10. The bioactive agent delivery device of claim 1 , wherein the paclitaxel is present in the hydrophobic bioactive composition layer in crystalline and amorphous forms.

11. A bioactive agent-eluting catheter comprising:

a catheter shaft;

an expandable balloon disposed on the catheter shaft, the expandable balloon comprising an expandable substrate; and

a hydrophilic polymer layer disposed over the substrate, the hydrophilic polymer layer comprising a hydrophilic polymer comprising poly(ethylene glycol);

a hydrophobic bioactive agent composition layer disposed over the surface of the hydrophilic polymer layer, the hydrophobic bioactive composition layer comprising one or more forms of paclitaxel; and

wherein the hydrophobic bioactive agent composition layer lacks the hydrophilic polymer.

12. The bioactive agent-eluting catheter of claim 11 , wherein the paclitaxel is present in the hydrophobic bioactive composition layer in crystalline and amorphous forms.

13. The bioactive agent-eluting catheter of claim 11 , wherein the paclitaxel releases from the device into an aqueous environment in under 30 seconds when exposed to an aqueous environment.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 8, 2025
From: SURMODICS, INC.
To: SURMODICS COATINGS, LLC
Reel/Frame 073928/0178 →
RELEASE OF SECURITY INTEREST Recorded Nov 24, 2025
From: MIDCAP FUNDING IV TRUST
To: SURMODICS, INC.; SURMODICS SHARED SERVICES, LLC; SURMODICS HOLDINGS, LLC; SURMODICS COATINGS, LLC; SURMODICS MD, LLC; SURMODICS COATINGS MFG, LLC; SURMODICS IVD, INC.; SURMODICS MD OPERATIONS, LLC; NORMEDIX, INC.
Reel/Frame 073690/0186 →
SECURITY INTEREST Recorded Aug 23, 2024
From: SURMODICS, INC.; SURMODICS SHARED SERVICES, LLC; SURMODICS HOLDINGS, LLC; SURMODICS COATINGS, LLC; SURMODICS MD, LLC; SURMODICS COATINGS MFG, LLC; SURMODICS IVD, INC.; SURMODICS MD OPERATIONS, LLC; NORMEDIX, INC.
To: MIDCAP FUNDING IV TRUST
Reel/Frame 068762/0423 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 22, 2018
From: CHAPPA, RALPH A.; BACH, ANDREW G.
To: SURMODICS, INC.
Reel/Frame 046174/0424 →